Friday, June 26, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 800 of 1,261

  1. US 8795669

    Stabilized formulations containing anti-PCSK9 antibodies

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 5, 2014 · Expires Jul 31, 2034

    granted

  2. US 8795668

    Methods for treating pulmonary fibrosis

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Aug 5, 2014 · Expires Jul 31, 2034

    granted

  3. US 8795674

    Methods and compositions for modulating immune tolerance

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 5, 2014 · Expires Jul 31, 2034

    granted

  4. US 8795677

    Treatment methods using an F1-V plague vaccine

    The United States of America as represented by the Secretary of the Army · Granted Aug 5, 2014 · Expires Jul 31, 2034

    granted

  5. US 8795703

    Stand-alone film and methods for making the same

    ATRIUM MEDICAL CORPORATION · Granted Aug 5, 2014 · Expires Jul 31, 2034

    granted

  6. US 8795650

    Derivation of unlimited quantities of neutrophils or monocyte/dendritic cells

    The Regents of the University of California · Granted Aug 5, 2014 · Expires Jul 31, 2034

    granted

  7. US 8796008

    Influenza A virus vaccines and inhibitors

    The Board of Regents of the University of Texas System · Granted Aug 5, 2014 · Expires Jul 31, 2034

    granted

  8. US 8796022

    Generation of functional basal forebrain cholinergic neurons from stem cells

    Northwestern University · Granted Aug 5, 2014 · Expires Jul 31, 2034

    granted

  9. US 8796428

    Erk1/2 posphorylation site specific antibody

    Julius-Maximilians-Universitat Wurzburg · Granted Aug 5, 2014 · Expires Jul 31, 2034

    granted

  10. US 8795964

    GRM3 mutations and use thereof for the diagnosis and treatment of melanoma

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 5, 2014 · Expires Jul 31, 2034

    granted

  11. US 8796332

    Compositions and methods for controlling infections

    Regents of the University of Minnesota · Granted Aug 5, 2014 · Expires Jul 31, 2034

    granted

  12. US 8796438

    Nucleic acids encoding inactive variants of human telomerase

    The Regents of the University of Colorado · Granted Aug 5, 2014 · Expires Jul 31, 2034

    granted

  13. US 8796209

    Compositions and methods related to anti-FGF agents

    The Regents of the University of California · Granted Aug 5, 2014 · Expires Jul 31, 2034

    granted

  14. US 8796308

    Modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Aug 5, 2014 · Expires Jul 31, 2034

    granted

  15. US 8796223

    Methods of inhibiting photoreceptor apoptosis

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Aug 5, 2014 · Expires Jul 31, 2034

    granted

  16. US 8795661

    Molecules with extended half-lives, compositions and uses thereof

    The Board of Regents of the University of Texas System · Granted Aug 5, 2014 · Expires Jul 31, 2034

    granted

  17. US 8795680

    Methods for conjugation of oligosaccharides or polysaccharides to protein carriers through oxime linkages via 3-deoxy-D-manno-octulsonic acid

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 5, 2014 · Expires Jul 31, 2034

    granted

  18. US 8795656

    Methods of treating rheumatoid arthritis by administering an anti-IL3 antibody

    Klinikum der Universität Regensburg · Granted Aug 5, 2014 · Expires Jul 31, 2034

    granted

  19. US 8791149

    Methods of treating traumatic brain injury using pro-neurogenic compounds

    The Board of Regents of the University of Texas System · Granted Jul 29, 2014 · Expires Jul 24, 2034

    granted

  20. US 8791136

    Substituted pyridine, pyridazine, pyrazine and pyrimidine compounds and methods for using the same

    Rigel Pharmaceuticals, Inc. · Granted Jul 29, 2014 · Expires Jul 24, 2034

    granted

  21. US 8791104

    1,4-benzodiazepine-2,5-diones with therapeutic properties

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jul 29, 2014 · Expires Jul 24, 2034

    granted

  22. US 8791107

    N-substituted oxazinopteridines and oxazinopteridinones

    Takeda Pharmaceutical Company Limited · Granted Jul 29, 2014 · Expires Jul 24, 2034

    granted

  23. US 8790869

    Renal cell carcinoma biomarkers

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 29, 2014 · Expires Jul 24, 2034

    granted

  24. US 8790679

    Intracutaneous paste composition

    XERIS PHARMACEUTICALS, INC. · Granted Jul 29, 2014 · Expires Jul 24, 2034

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.